These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8630640)

  • 21. A comparison of faecal blood loss caused by tenoxicam and piroxicam in normal healthy male volunteers.
    Bird HA; Hill J; Haw WM; Dixon JS; Harris PA; Wright V
    Curr Med Res Opin; 1985; 9(8):524-8. PubMed ID: 3875450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.
    Tavakoli M
    Pharmacoeconomics; 2003; 21(6):443-54. PubMed ID: 12678570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
    Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B
    Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder.
    Vidal L; Kneer W; Baturone M; Sigmund R
    Inflamm Res; 2001 Mar; 50 Suppl 1():S24-9. PubMed ID: 11339517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis.
    Huskisson EC; Ghozlan R; Kurthen R; Degner FL; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():29-34. PubMed ID: 8630633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
    Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
    Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local tissue tolerability of meloxicam, a new NSAID: indications for parenteral, dermal and mucosal administration.
    Stei P; Kruss B; Wiegleb J; Trach V
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():44-50. PubMed ID: 8630637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.
    Hosie J; Distel M; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():39-43. PubMed ID: 8630635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance.
    Engelhardt G; Homma D; Schlegel K; Utzmann R; Schnitzler C
    Inflamm Res; 1995 Oct; 44(10):423-33. PubMed ID: 8564518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of meloxicam in patients with rheumatoid arthritis.
    Lemmel EM; Bolten W; Burgos-Vargas R; Platt P; Nissilä M; Sahlberg D; Björneboe O; Baumgartner H; Valat JP; Franchimont P; Bluhmki E; Hanft G; Distel M
    J Rheumatol; 1997 Feb; 24(2):282-90. PubMed ID: 9034984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study.
    Lazzaroni M; Anderloni A; Bianchi Porro G
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):833-9. PubMed ID: 11474314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meloxicam.
    Fleischmann R; Iqbal I; Slobodin G
    Expert Opin Pharmacother; 2002 Oct; 3(10):1501-12. PubMed ID: 12387696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee.
    Goei Thè HS; Lund B; Distel MR; Bluhmki E
    Osteoarthritis Cartilage; 1997 Jul; 5(4):283-8. PubMed ID: 9404473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
    Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
    Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials.
    Schoenfeld P
    Am J Med; 1999 Dec; 107(6A):48S-54S. PubMed ID: 10628593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers.
    van Kraaij DJ; Hovestad-Witterland AH; de Metz M; Vollaard EJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):644-7. PubMed ID: 12047490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam.
    Jick SS
    Pharmacotherapy; 2000 Jul; 20(7):741-4. PubMed ID: 10907963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lornoxicam, indomethacin and placebo: comparison of effects on faecal blood loss and upper gastrointestinal endoscopic appearances in healthy men.
    Warrington SJ; Debbas NM; Farthing M; Horton M; Johnston A; Thillainayagam A; Turner P; Ferber H
    Postgrad Med J; 1990 Aug; 66(778):622-6. PubMed ID: 2217030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators.
    Yocum D; Fleischmann R; Dalgin P; Caldwell J; Hall D; Roszko P
    Arch Intern Med; 2000 Oct; 160(19):2947-54. PubMed ID: 11041902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.